ATRX and anaplastic astrocytoma: In the same study, focusing on anaplastic astrocytoma, WHO grade 3, the molecular characteristics were reported as follows: IDH1 mutation was present in two out of four cases (50%), ATRX loss was observed in three out of four cases (75%), and p53 mutation was detected in three out of four cases (75%).